These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 17098333
1. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease. Pritchard AL, Harris J, Pritchard CW, Coates J, Haque S, Holder R, Bentham P, Lendon CL. Neurobiol Aging; 2008 Mar; 29(3):341-7. PubMed ID: 17098333 [Abstract] [Full Text] [Related]
2. Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease. Pritchard AL, Ratcliffe L, Sorour E, Haque S, Holder R, Bentham P, Lendon CL. Int J Geriatr Psychiatry; 2009 Sep; 24(9):1020-5. PubMed ID: 19235789 [Abstract] [Full Text] [Related]
4. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients. Middle F, Pritchard AL, Handoko H, Haque S, Holder R, Bentham P, Lendon CL. J Alzheimers Dis; 2010 Sep; 20(2):561-7. PubMed ID: 20182055 [Abstract] [Full Text] [Related]
5. Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease. Pritchard AL, Pritchard CW, Bentham P, Lendon CL. Dement Geriatr Cogn Disord; 2008 Sep; 26(3):257-60. PubMed ID: 18841010 [Abstract] [Full Text] [Related]
8. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study. Angelucci F, Bernardini S, Gravina P, Bellincampi L, Trequattrini A, Di Iulio F, Vanni D, Federici G, Caltagirone C, Bossù P, Spalletta G. J Alzheimers Dis; 2009 Sep; 17(1):203-11. PubMed ID: 19494443 [Abstract] [Full Text] [Related]
9. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type. Sato N, Ueki A, Ueno H, Shinjo H, Morita Y. J Alzheimers Dis; 2009 Sep; 17(2):441-8. PubMed ID: 19363270 [Abstract] [Full Text] [Related]
11. Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease. Craig D, Donnelly C, Hart D, Carson R, Passmore P. Am J Med Genet B Neuropsychiatr Genet; 2007 Jan 05; 144B(1):126-8. PubMed ID: 16967466 [Abstract] [Full Text] [Related]
12. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Engelborghs S, Dermaut B, Mariën P, Symons A, Vloeberghs E, Maertens K, Somers N, Goeman J, Rademakers R, Van den Broeck M, Pickut B, Cruts M, Van Broeckhoven C, De Deyn PP. Neurobiol Aging; 2006 Feb 05; 27(2):285-92. PubMed ID: 16399213 [Abstract] [Full Text] [Related]
17. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease. Ito T, Meguro K, Akanuma K, Meguro M, Lee E, Kasuya M, Ishii H, Mori E. J Clin Neurosci; 2007 Sep 05; 14(9):850-5. PubMed ID: 17587584 [Abstract] [Full Text] [Related]
19. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia. Al Hadithy AF, Ivanova SA, Pechlivanoglou P, Semke A, Fedorenko O, Kornetova E, Ryadovaya L, Brouwers JR, Wilffert B, Bruggeman R, Loonen AJ. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr 30; 33(3):475-81. PubMed ID: 19439249 [Abstract] [Full Text] [Related]
20. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene. Craig D, Hart DJ, Carson R, McIlroy SP, Passmore AP. Neurosci Lett; 2004 Sep 16; 368(1):33-6. PubMed ID: 15342129 [Abstract] [Full Text] [Related] Page: [Next] [New Search]